A novel solvent-free co-grinding preparation improves curcumin bioavailability in healthy volunteers: A single-center crossover study
- PMID: 36685407
- PMCID: PMC9852671
- DOI: 10.1016/j.heliyon.2023.e12829
A novel solvent-free co-grinding preparation improves curcumin bioavailability in healthy volunteers: A single-center crossover study
Abstract
Curcumin, from the rhizome of turmeric (Curcuma longa L.), has a wide variety of biological activities. Unfortunately, its poor water-solubility greatly limits its bioavailability. The purpose of this study was to evaluate CUMINUP60®, a novel preparation utilizing a solvent-free, co-grinding method designed to improve curcumin's bioavailability. We performed a single-center crossover experiment to compare the new product with standard 95% curcumin in the blood plasma of twelve healthy adults (10 males, 2 females). Total bioavailability of curcumin and its sulfate and glucuronide conjugates from the test product, measured by their areas under the curve over 12 h (AUC0-T), showed a combined increase of 178-fold over standard curcumin and its conjugates from the reference product. The new product represents a significant improvement for providing greater bioavailability of curcumin, as compared with several other branded preparations. It therefore has broad applications for preparing curcumin as a more effective health ingredient in functional foods, beverages, and nutraceuticals.
Keywords: CUMINUP60®; Curcumin; Oral bioavailability; Pharmacokinetics.
© 2023 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as a potential competing interest: CUMINUP60® is the registered trademark name of Chenland Nutritionals, Inc., for the test product used in the present study. Chenland Nutritionals, Inc., had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
Similar articles
-
Highly bioavailable curcumin preparation with a co-grinding and solvent-free process.Food Sci Nutr. 2020 Oct 7;8(12):6415-6425. doi: 10.1002/fsn3.1930. eCollection 2020 Dec. Food Sci Nutr. 2020. PMID: 33312527 Free PMC article.
-
Safety evaluation of CuminUP60® - A novel curcumin complex.Toxicol Rep. 2022 Jun 14;9:1308-1315. doi: 10.1016/j.toxrep.2022.06.007. eCollection 2022. Toxicol Rep. 2022. PMID: 36518434 Free PMC article.
-
Biomedical Applications and Bioavailability of Curcumin-An Updated Overview.Pharmaceutics. 2021 Dec 7;13(12):2102. doi: 10.3390/pharmaceutics13122102. Pharmaceutics. 2021. PMID: 34959384 Free PMC article. Review.
-
Comparative bioavailability of curcuminoids from a water-dispersible high curcuminoid turmeric extract against a generic turmeric extract: a randomized, cross-over, comparative, pharmacokinetic study.J Pharm Pharmacol. 2021 Apr 27;73(6):816-823. doi: 10.1093/jpp/rgab028. J Pharm Pharmacol. 2021. PMID: 33755149 Clinical Trial.
-
Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications.Front Pharmacol. 2020 Sep 15;11:01021. doi: 10.3389/fphar.2020.01021. eCollection 2020. Front Pharmacol. 2020. PMID: 33041781 Free PMC article. Review.
References
-
- Jurenka J.S. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Alternative Med. Rev. 2009;14(2):141–153. PMID: 19594223. - PubMed
-
- Kishimoto A., Imaizumi A., Wada H., Yamakage H., Satoh-Asahara N., Hashimoto T., Hasegawa K. Newly developed highly bioavailable curcumin formulation, curcuRougeTM, reduces neutrophil/lymphocyte ratio in the elderly: a double-blind, placebo-controlled clinical trial. J. Nutr. Sci. Vitaminol. 2021;67(4):249–252. doi: 10.3177/jnsv.67.249. PMID: 34471000. - DOI - PubMed
LinkOut - more resources
Full Text Sources